Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)

NCT04135794 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04135794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04135794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Active, not recruiting
Start date
December 9, 2019
Completion date
November 30, 2027
Enrollment
377 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer